Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chewing Clopidogrel in NSTEMI
NCT00889044Phase 3Unknown
- Sponsor
- Sheba Medical Center
- Start
- Apr 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in non-ST-elevation myocardial infarction (NSTEMI) comparing clopidogrel by chewing with Placebo (2 arms). Primary endpoints: Platelet aggregation at 6 months and Bleeding events at 6 months. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00889044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889044.